The effect of cholinesterase inhibitors on risk of nursing home placement among medicaid beneficiaries with dementia

被引:18
作者
Becker, Marion [1 ]
Andel, Ross
Rohrer, Lodi
Banks, Steven M.
机构
[1] Univ S Florida, Florida Mental Hlth Inst, Tampa, FL 33612 USA
[2] Univ S Florida, Sch Aging Studies, Tampa, FL 33612 USA
[3] Florida Alzheimers Dis Res Ctr, Tampa, FL USA
关键词
dementia; Alzheimer disease; nursing home; institutionalization;
D O I
10.1097/00002093-200607000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The purpose of this study was to explore the effect of therapy with cholinesterase inhibitors (ChE-Is) on the risk of nursing home (NH) placement in patients with dementia. Participants were enrolled in the Florida Medicaid program during the fiscal year 1998 to 1999 (N = 1188). Of these, 378 had Alzheimer disease as their only dementia diagnosis. About 50% of the sample received ChE-Is. The total follow-up period was 36 months. We used Cox proportional hazard regressions to estimate the risk of NH placement. After adjusting for age, sex, race, and cooccurring diagnoses, we found that dementia patients receiving ChE-Is had reduced risk of NH placement by 28% at 12 months [hazard ratio (HR) = 0.72, 95% confidence interval (CI) 0.55-0.94] and 21% at 18 months (HR = 0.79, 95% Cl 0.62-0.99). The reduction in risk was more pronounced in patients with Alzheimer disease only and was still significant at 24 months after baseline (HR = 0.66, 95% CI 0.43-0.99). At 36 months.. the association between taking ChE-Is and risk of NH placement was not significant and the proportion of participants placed in a nursing was almost identical. Therapy with ChE-Is may temporarily reduce the risk of NH placement in Medicaid beneficiaries with dementia thereby improving quality of life and preserving personal an societal resources.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 38 条
[11]  
CRAYTON G, 2004, MED REF S FUT FLOR M
[12]   Use of cholinesterase inhibitors in clinical practice - Evidence-based recommendations [J].
Cummings, JL .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 11 (02) :131-145
[13]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[14]   Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression [J].
Farlow, MR ;
Hake, A ;
Messina, J ;
Hartman, R ;
Veach, J ;
Anand, R .
ARCHIVES OF NEUROLOGY, 2001, 58 (03) :417-422
[15]   Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden [J].
Feldman, H ;
Gauthier, S ;
Hecker, J ;
Vellas, B ;
Emir, B ;
Mastey, V ;
Subbiah, P .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (06) :737-744
[16]   Global prevalence of dementia: a Delphi consensus study [J].
Ferri, CP ;
Prince, M ;
Brayne, C ;
Brodaty, H ;
Fratiglioni, L ;
Ganguli, M ;
Hall, K ;
Hasegawa, K ;
Hendrie, H ;
Huang, YQ ;
Jorm, A ;
Mathers, C ;
Menezes, PR ;
Rimmer, E ;
Scazufca, M .
LANCET, 2005, 366 (9503) :2112-2117
[17]   Characteristics predicting nursing home admission in the program of all-inclusive care for elderly people [J].
Friedman, SM ;
Steinwachs, DM ;
Rathouz, PJ ;
Burton, LC ;
Mukamel, DB .
GERONTOLOGIST, 2005, 45 (02) :157-166
[18]   Predictors of institutionalization of cognitively impaired elders: Family help and the timing of placement [J].
Gaugler, JE ;
Edwards, AB ;
Femia, EE ;
Zarit, SH ;
Stephens, MAP ;
Townsend, A ;
Greene, R .
JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2000, 55 (04) :P247-P255
[19]   Donepezil is associated with delayed nursing home placement in patients with Alzheimer's disease [J].
Geldmacher, DS ;
Provenzano, G ;
McRae, T ;
Mastey, V ;
Ieni, JR .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (07) :937-944
[20]   Cognitive impairment and quality-of-life - Views of providers of long-term care services [J].
Gessert, CE ;
Hyer, K ;
Kane, RL ;
Rockwood, T ;
Brassard, AB ;
Desjardins, K ;
Kane, RA .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2005, 19 (02) :85-90